Related references
Note: Only part of the references are listed.Targeting Protein Folding: A Novel Approach for the Treatment of Pathogenic Bacteria
Nicolas J. Scheuplein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control
Matteo Bassetti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
FKBP Ligands-Where We Are and Where to Go?
Juergen M. Kolos et al.
FRONTIERS IN PHARMACOLOGY (2018)
A miniaturized peptidyl-prolyl isomerase enzyme assay
Mirella Vivoli et al.
ANALYTICAL BIOCHEMISTRY (2017)
Development, synthesis and structure-activity-relationships of inhibitors of the macrophage infectivity potentiator (Mip) proteins of Legionella pneumophila and Burkholderia pseudomallei
Florian Seufert et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity
Anastasija Reimer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
FKBPs in bacterial infections
Can M. Unal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
ESKAPEing the labyrinth of antibacterial discovery
Ruben Tommasi et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial Immunophilins
Darren W. Begley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
YASARA View-molecular graphics for all devices-from smartphones to workstations
Elmar Krieger et al.
BIOINFORMATICS (2014)
Targeting virulence: can we make evolution-proof drugs?
Richard C. Allen et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Unveiling the Intracellular Survival Gene Kit of Trypanosomatid Parasites
Daniella Castanheira Bartholomeu et al.
PLOS PATHOGENS (2014)
The structure of a Burkholderia pseudomallei immunophilin-inhibitor complex reveals new approaches to antimicrobial development
Isobel H. Norville et al.
BIOCHEMICAL JOURNAL (2011)
A Burkholderia pseudomallei Macrophage Infectivity Potentiator-Like Protein Has Rapamycin-Inhibitable Peptidylprolyl Isomerase Activity and Pleiotropic Effects on Virulence
Isobel H. Norville et al.
INFECTION AND IMMUNITY (2011)
Pipecolic Acid Derivatives As Small-Molecule Inhibitors of the Legionella MIP Protein
Christina Juli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Transcriptome Analysis of Neisseria meningitidis in Human Whole Blood and Mutagenesis Studies Identify Virulence Factors Involved in Blood Survival
Hebert Echenique-Rivera et al.
PLOS PATHOGENS (2011)
IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
R. Z. Cer et al.
NUCLEIC ACIDS RESEARCH (2009)
Solution structure of the Legionella pneumophila Mip-rapamycin complex
Andreas Ceymann et al.
BMC STRUCTURAL BIOLOGY (2008)
Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages
R Leuzzi et al.
MOLECULAR MICROBIOLOGY (2005)
Crystal structure of Mip, a prolylisomerase from Legionella pneumophila
A Riboldi-Tunnicliffe et al.
NATURE STRUCTURAL BIOLOGY (2001)
Receptor accessory folding helper enzymes:: the functional role of peptidyl prolyl cis/trans isomerases
C Schiene-Fischer et al.
FEBS LETTERS (2001)
Share Paper
